Browsing by Author Trefzer, Uwe

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 4 of 4
Issue DateTitleAuthor(s)Citation
2006Bcl-2 Antisense (oblimersen sodium) Plus Dacarbazine in Patients With Advanced Melanoma: The Oblimersen Melanoma Study Group.Millward, Michael; Bedikian, Agop Y.; Conry, Robert; DeConti, Ronald; Gore, Martin; Haluska, Frank G.; Hersey, Peter; Hersh, Evan M.; Kirkwood, John M; Pavlick, Anna C.; Pehamberger, Hubert; Trefzer, Uwe; MedicineBcl-2 Antisense (oblimersen sodium) Plus Dacarbazine in Patients With Advanced Melanoma: The Oblimersen Melanoma Study Group., JOURNAL OF CLINICAL ONCOLOGY 2005, vol.24,(29),2006,pp 4738-4745
2012Dabrafenib in patients with Val600Glu or Val600Lys BRAF-mutant melanoma metastatic to the brain (BREAK-MB): a multicentre, open-label, phase 2 trialKefford, Richard (Rick); Long, Georgina; Algazi, Alain; Ascierto, Paolo; Chapman, Paul; Davies, Michael; et al, Various; Hauschild, A; Mortier, Laurent; Puzanov, Igor; Robert, C; Tawbi, Hussein; Trefzer, Uwe; Western Clinical School: Westmead Millennium Institute; Central Clinical School: The Sydney Cancer CentreDabrafenib in patients with Val600Glu or Val600Lys BRAF-mutant melanoma metastatic to the brain (BREAK-MB): a multicentre, open-label, phase 2 trial, The Lancet Oncology, vol.13, 11, 2012,pp 1087-1095
2011Merkel Cell Polyomavirus Status Is Not Associated with Clinical Course of Merkel Cell CarcinomaScolyer, Richard; Thompson, John; Becker, Jurgen; Eib, Steffi; Haferkamp, Sebastian; Houben, Roland; Kneitz, Hermann; Moore, Patrick; Peitsch, Wiebke; Pfohler, Claudia; Schrama, David; Shuda, Masahiro; Trefzer, Uwe; Zapatka, Marc; Central Clinical School: Pathology; Central Clinical School: SurgeryMerkel Cell Polyomavirus Status Is Not Associated with Clinical Course of Merkel Cell Carcinoma, The Journal of Investigative Dermatology, vol.131, 8, 2011,pp 1631-1638
2010Results of a Multicenter, Randomized, Double-Blind Phase 2/3 Study of Lenalidomide in the Treatment of Pretreated Relapsed or Refractory Metastatic Malignant MelanomaHamilton, Anne; Eisen, Tim; Glaspy, John; Hersey, Peter; Jungnelius, Jarl; Knight, Robert; Millward, Michael; Trefzer, Uwe; Central Clinical School: MedicineResults of a Multicenter, Randomized, Double-Blind Phase 2/3 Study of Lenalidomide in the Treatment of Pretreated Relapsed or Refractory Metastatic Malignant Melanoma, Cancer, vol.116, 1,pp 146-154